Home > Balance Sheet > GLAXOSMITHKLINE PHARMACEUTICALS

GLAXOSMITHKLINE PHARMACEUTICALS
Deferred Tax Assets / Liabilities

    Back to Balance Sheet
GLAXOSMITHKLINE PHARMACEUTICALS is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
Best 1M Momentum Mid Cap Stocks
COMMUNITY POLL
for GLAXOSMITHKLINE PHARMACEUTICALS
Please provide your vote to see the results

GLAXOSMITHKLINE PHARMACEUTICALS Last 5 Year Deferred Tax Assets / Liabilities History

[Consolidated]

Mar2023Mar2022Mar2021Mar2020Mar2019
Deferred Tax Assets / Liabilities ₹-134 Cr₹-113 Cr₹-103 Cr₹-110 Cr₹-62 Cr

What is the latest Deferred Tax Assets / Liabilities ratio of GLAXOSMITHKLINE PHARMACEUTICALS ?

The latest Deferred Tax Assets / Liabilities ratio of GLAXOSMITHKLINE PHARMACEUTICALS is ₹-134 Cr based on Mar2023 Consolidated results.
Year Deferred Tax Assets / Liabilities
Mar2023₹-134 Cr
Mar2022₹-113 Cr
Mar2021₹-103 Cr
Mar2020₹-110 Cr
Mar2019₹-62 Cr

How is Deferred Tax Assets / Liabilities of GLAXOSMITHKLINE PHARMACEUTICALS Trending?

Years Deferred Tax Assets / Liabilities % Change
Mar2023 ₹-134 Cr
Negative
Mar2022 ₹-113 Cr
Negative
Mar2021 ₹-103 Cr
Negative
Mar2020 ₹-110 Cr
Negative
Mar2019 ₹-62 Cr -

Compare Deferred Tax Assets / Liabilities of peers of GLAXOSMITHKLINE PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAXOSMITHKLINE PHARMACEUTICALS ₹41,171.0 Cr 3.2% 16.9% 90.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹356,673.0 Cr -2.9% 0% 59.6% Stock Analytics
CIPLA ₹119,930.0 Cr 5.8% 6.2% 60.9% Stock Analytics
DIVIS LABORATORIES ₹109,446.0 Cr 5% 8% 25.9% Stock Analytics
ZYDUS LIFESCIENCES ₹108,261.0 Cr -2.6% 15.3% 114.4% Stock Analytics
DR REDDYS LABORATORIES ₹97,830.6 Cr 0.9% -1.5% 32.2% Stock Analytics


GLAXOSMITHKLINE PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLAXOSMITHKLINE PHARMACEUTICALS

3.2%

16.9%

90.5%

SENSEX

2%

2.3%

22.2%


You may also like the below Video Courses